Key facts
- It has raised $14.0M; the latest was Early Stage VC ($14.0M) in Nov 2025.
- Notable investors include GL Ventures, Mengniu Founding Industry Management, Sirio Pharma.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Maisheng Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Maisheng Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maisheng Health
Manufacturer of sports nutrition foods designed to support athletic performance, recovery, and daily health. The company offers scientifically formulated endurance nutrition, liquid protein products, functional ingredient preservation, and athlete-focused product development, enabling athletes and fitness-oriented consumers to enhance energy replenishment, improve nutrient absorption, and achieve sustained physical performance.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shanghai, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Maisheng Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maisheng Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maisheng Health in its N-PORT filings yet. We sweep new filings monthly.